Figure 1.
Adjusted inpatient and postdischarge fluoroquinolone use between 2014 and 2017. Fluoroquinolone use was determined per quarter and is adjusted for predicted 30-day mortality, age, and 31 Elixhauser comorbidity indicators.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.